Global Bioenergies publishes annual financial results
Group net loss of €11.8m in 2021 Gross cash position of €20.9m at 31 December 2021 Paris, 2 March 2022: The Board of Directors of Global Bioenergies, at its meeting…
Read More TP ICAP Midcap initiates coverage of Global Bioenergies share
Evry, 31 January 2022: TP ICAP Midcap has initiated coverage of the Global Bioenergies share (Euronext Growth: ALGBE) and today publishes a detailed analysis for its clients describing the Group’s…
Read More Global Bioenergies successfully completes a fundraising for a total amount of €14.5 million
Evry, 14 December 2021: Global Bioenergies (the “Company”) is today announcing the successful completion of its capital increase for a total amount of €14.5M, without preferential subscription rights for shareholders…
Read More Global Bioenergies launches a fundraising operation of approximately €10 million
Capital increase aimed at institutional investors and at retail investors (via the PrimaryBid platform) Irrevocable subscription commitments from the L’Oréal group and the Cristal Union group, the historical shareholders Closing…
Read More Kepler Cheuvreux initiates coverage of the Global Bioenergies share
Evry, 09 November 2021: Kepler Cheuvreux has initiated coverage of the Global Bioenergies share (Euronext Growth: ALGBE) and today publishes a 50-page report setting out the stages of the Group’s development,…
Read More Global Bioenergies to present at the Lytham Partners Fall 2021 Investor Conference
Evry, 4 October 2021: Global Bioenergies (Euronext Growth: ALGBE), announced today that it will present at the Lytham Partners Fall 2021 Investor Conference on October 6, 2021 at 9:30 AM…
Read More 